Navigation Links
Alternatives Available Nationwide to Addictive Benzodiazepines for Anxiety
Date:1/2/2017

BIRMINGHAM, Ala., Jan. 2, 2017 /PRNewswire/ -- The pharmaceutical research company TPD LLC (Trends in Pharma Development) announced that the PanX® new class of medicines intended for the treatment of anxiety are now available nationwide as prescription compounded drugs.

Two US patents 9,446,030 and 9,517,231 were recently issued to the company in September and December, respectively.  The patents broadly cover dual drug combinations of historically-safe active ingredients that are being re-purposed for the treatment of anxiety disorders, such as social anxiety disorder, panic, and PTSD. The combinations were designed to suppress the multiple symptoms of acute anxiety.

The PanX® drugs are intended as "as needed" alternatives to benzodiazepines (e.g., Xanax® or Valium®) that are addictive, have the potential for abuse, and are Controlled Substances.  However, the active ingredients in the PanX® brand, beta blockers and antiemetic motion sickness agents, have no history of addiction or abuse in five decades of prescription or over-the-counter use.  The company's goal for the patented new class of medicines is to provide effective, fast-acting, yet safer alternatives to benzodiazepines.

According to a leading authority on anxiety therapies, Professor Charles B. Nemeroff, MD PhD, Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami, "A number of patients with prominent anxiety symptoms do not respond or cannot tolerate currently available treatments. This novel approach combining two medications with distinct mechanisms of action has the potential to fill an important niche in the management of such patients."

TPD has contracted with Pine Pharmaceuticals and Pine Pharmacy of New York, and Custom Meds of Florida to produce the products as prescription compounded drugs.  The combination drug products are available in 49 states as patient-specific prescriptions by mail order and/or as "office use" medications administered by physicians, for instance in medical procedures when patients are anxious or fearful.  For additional information see www.PanX.us.

TPD is also pursuing the clinical development of selected PanX® drugs to seek product approval by the US Food and Drug Administration (FDA).

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alternatives-available-nationwide-to-addictive-benzodiazepines-for-anxiety-300384404.html


'/>"/>
SOURCE TPD LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. RI Physical Therapist Discusses Alternatives to Rising Opioid Use
2. EpiBiome Secures $6 Million Series A Financing to Develop Alternatives to Small-Molecule Antibiotics for Agriculture
3. KaloBios to Reduce Workforce, Explore Strategic Alternatives
4. The Manufacturer of the SynCardia Total Artificial Heart has Hired Investment Bank Canaccord Genuity, Inc. to Advise the BOD on Strategic Alternatives to Maximize Stakeholder Equity
5. Unilife Announces Review of Strategic Alternatives
6. As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation
7. Pessaries and Other Vaginal Mesh Alternatives Discussed by Life Care Solutions Group
8. BioNet Received Thai FDA Approval of the Worlds Only Available Recombinant Monovalent Acellular Pertussis (aP) Vaccine
9. Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option
10. Zymo Research Announces Nucleic Acid Purification Kits Now Available on Amazon.com
11. In-home PFT Testing Is Now Available to Patients with ndd Medicals Mobile EasyOne Pro
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... N.Y. , May 5, 2017  Hill-Rom Holdings, ... will add approximately 100,000 square feet to its Welch ... September 2016 its commitment to bring more than 100 ... , where Welch Allyn has maintained a significant presence ... help accommodate these new positions, a large portion of ...
(Date:5/4/2017)... CAESAREA, Israel , May 4, 2017  DarioHealth ... with mobile health and big data solutions, today announced ... an A&D Company, and STI Technologies Limited to lower ... effective immediately. Through STI,s innoviCares card, which is available ... , DarioHealth customers will be eligible for additional ...
(Date:5/3/2017)... 3, 2017  Getinge, a leading global provider ... enhancement and cost efficiency within healthcare and life ... contemporary practice demonstrating that intra-aortic balloon counterpulsation (IABC) ... ill patients. The single-center, retrospective, observational study showed ... MEGA ® 50cc intra-aortic balloon (IAB) in ...
Breaking Medicine Technology:
(Date:5/26/2017)... York, NY (PRWEB) , ... May 26, 2017 , ... ... Health & Wound Care" campaign in USA Today, which will educate readers on how ... side of the campaign, a large focus is placed on melanoma. Dancing with the ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Amir Qureshi, MD ... a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has ... are pleased to be the first in Arkansas to introduce the most powerful SCS ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... the first ever copper, antimicrobial, mesh back 24/7 task chair specifically designed for ... applications. “We are thrilled to partner with Cupron® to provide customers with ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... ... ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of Bob Massey and his ... of published authors, Bob and Margaret Massey. Bob Massey is small in stature but ... leather tough." His love for others is apparent in all of his life decisions. ...
Breaking Medicine News(10 mins):